Waverley, 3149, VIC,
Australia
Chemtronics Biomedical Engineering, a division of Cabrini Technology Group Technographics
Chemtronics Biomedical Engineering, a division of Cabrini Technology Group Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Chemtronics Biomedical Engineering, a division of Cabrini Technology Group and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 200 Chemtronics Biomedical Engineering, a division of Cabrini Technology Group employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Chemtronics Biomedical Engineering, a division of Cabrini Technology Group has purchased the following applications: Oracle JD Edwards EnterpriseOne for ERP Financial in 2009, Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2017, Proofpoint Email Security and Protection for Secure Email Gateways (SEGs) in 2018 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Chemtronics Biomedical Engineering, a division of Cabrini Technology Group is running and its propensity to invest more and deepen its relationship with Oracle , Microsoft , Proofpoint or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Chemtronics Biomedical Engineering, a division of Cabrini Technology Group revenues, which have grown to $25.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Chemtronics Biomedical Engineering, a division of Cabrini Technology Group intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Chemtronics Biomedical Engineering, a division of Cabrini Technology Group Tech Stack and Enterprise Applications
Chemtronics Biomedical Engineering, a division of Cabrini Technology Group ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle JD Edwards EnterpriseOne | ERP Financial | ERP | n/a | 2009 | 2009 |
In 2009, Chemtronics Biomedical Engineering implemented Oracle JD Edwards EnterpriseOne as its ERP Financial system to centralize core finance and inventory accounting across Australian and New Zealand operations. Oracle JD Edwards EnterpriseOne was deployed to support general ledger, accounts payable, accounts receivable, journal processing, month-end close, and financial reporting for area managers, aligning the Company ERP Financial application with corporate accounting controls and statutory reporting workflows.
The implementation included configuration of transaction modules and control processes for bank payments, international payments, payroll file approvals, fringe benefits tax preparation, capex reporting, and petty cash management. Operational capabilities implemented in Oracle JD Edwards EnterpriseOne included journal creation and approval workflows, GL reconciliations, accrual processing, vendor payment runs with approval thresholds up to $1,400,000, and inventory stock take consolidation across more than sixty locations.
Integrations and migration work centered on absorbing another entitys accounts payable and accounts receivable modules into JD Edwards, executing interfacing and testing in collaboration with both companies IT teams. The project moved end to end AP invoice processing into JD Edwards and integrated A/R collections into the JDE ledger, while the finance team continued to review and approve fortnightly payroll files and to create international payments using the JD Edwards payment engine.
Governance and process restructuring emphasized centralized approval workflows, role based journal and payment approvals, and hands on operational transition support from finance staff. Finance personnel conducted training for newly hired AP and AR officers, managed full AP processing after a four month transition period, liaised with external auditors for reconciliations, and maintained controls over 100 corporate Master cards and petty cash floats under the Oracle JD Edwards EnterpriseOne ERP Financial deployment.
|
Chemtronics Biomedical Engineering, a division of Cabrini Technology Group IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft Azure Cloud Services | Application Hosting and Computing Services | IaaS | n/a | 2017 | 2017 |
In 2017, Chemtronics Biomedical Engineering, a division of Cabrini Technology Group deployed Microsoft Azure Cloud Services to host and operate its public website. The Microsoft Azure Cloud Services implementation is classified in the Application Hosting and Computing Services category and provides scalable compute, managed platform services, and cloud storage to underpin the company web presence.
The deployment focuses on web hosting and web application compute, supporting web content management and customer facing site operations, with common cloud capabilities such as virtual machine provisioning, platform services for application runtime, automated scaling and managed storage to stabilize availability. Operational governance is aligned to IT managed cloud provisioning, release cycles and monitoring workflows to maintain the website and associated application services.
|
Chemtronics Biomedical Engineering, a division of Cabrini Technology Group CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Proofpoint | Legacy | Proofpoint Email Security and Protection | Secure Email Gateways (SEGs) | CyberSecurity | n/a | 2018 | 2018 |
In 2018, Chemtronics Biomedical Engineering, a division of Cabrini Technology Group, deployed Proofpoint Email Security and Protection. The implementation positioned Proofpoint Email Security and Protection as the organization’s Secure Email Gateways (SEGs) solution to secure corporate email and support IT and security operations.
The deployment was configured to deliver core Secure Email Gateways (SEGs) capabilities including inbound and outbound spam filtering, malware and phishing detection, attachment inspection and sandboxing, URL defense, content and policy enforcement, quarantine management, and centralized reporting. Administrators used the Proofpoint administrative console to define policy sets, manage quarantine workflows, and tune detection sensitivity consistent with manufacturing industry email patterns.
Architecturally the implementation followed a cloud gateway model, with mail flow routed through Proofpoint’s inspection layer prior to delivery to on premises or hosted mailboxes. The configuration included SMTP mail flow inspection and centralized log capture for security review, enabling IT and security teams to operate a single control plane for email threat management across the company.
Operational governance centered on IT and security teams operating the Proofpoint administrative interface, onboarding user groups, and establishing incident response and user notification workflows for suspected phishing and malware events. Proofpoint Email Security and Protection was documented as the company email security control within corporate IT tooling, supporting ongoing policy updates and operational oversight without external implementation partner involvement.
|
|
|
|
|
Secure Web Gateways (SWG) | CyberSecurity |
|
2013 | 2013 |
|
IT Decision Makers and Key Stakeholders at Chemtronics Biomedical Engineering, a division of Cabrini Technology Group
Apps Being Evaluated by Chemtronics Biomedical Engineering, a division of Cabrini Technology Group Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||